Home Tags BioSig Technologies
Tag: BioSig Technologies
The trial will occur in hospitalized patients who have confirmed infection with SARS-CoV-2 and require supplemental oxygen.
"We are doing everything in our power to ensure it gets tested and brought to market as soon as possible,” says BioSig Technologies Chairman and CEO Kenneth L. Londoner of the company's new Vicromax.
Gentling was previously an investment officer at the Mayo Clinic.
BioSig follows the lead of Xerox Corp. in opening a new technology center elsewhere in the country.